Also from this source

You just read:

Oncolytics Biotech® Inc. Completes Patient Enrollment in U.S. Phase 2 Clinical Trial Investigating REOLYSIN® in Combination with Paclitaxel and Carboplatin in Head and Neck Cancers

News provided by

Oncolytics Biotech Inc.

Mar 24, 2011, 07:30 ET